Twenty-seven states and the District of Columbia have sued the bankrupt genetic testing company 23andMe in an effort to block ...

Twenty-eight states argue that 23andMe must secure explicit, informed consent from all 15 million affected users before ...

Twenty-seven states and Washington, D.C., have filed a lawsuit to block the sale of customers’ DNA and data without their ...

The possible sale of 23andMe’s genetic data could set a precedent for future cases where companies look to offload ...

WASHINGTON — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block ...

New York and more than two dozen other U.S. states sued 23andMe to challenge the sale of its customers' private information ...

D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces ...

People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest ...

More than two dozen states, along with the District of Columbia ... When it filed for bankruptcy, 23andMe said the personal information of customers could be accessed, transferred or sold as ...

WASHINGTON — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent.

(Reuters) -New York and more than two dozen other U.S. states sued 23andMe to challenge the sale of its customers' private information after the genetic testing company filed for bankruptcy in March.